Silver Spring, MD, United States of America

Vincent Dussupt

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Vincent Dussupt

Introduction

Vincent Dussupt is an accomplished inventor based in Silver Spring, MD. He has made significant contributions to the field of medical science, particularly in the development of antibodies for viral infections. His work focuses on addressing the challenges posed by the Zika virus and its related diseases.

Latest Patents

Vincent Dussupt holds a patent for "Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination." This invention provides antibodies that are useful in treating or preventing Zika virus infections. The novel polypeptides described in the patent can be utilized alone or as components of larger molecules, such as antibodies or antibody fragments.

Career Highlights

Throughout his career, Dussupt has worked with notable organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Beth Israel Deaconess Medical Center. His experience in these institutions has allowed him to contribute to important research and development projects.

Collaborations

Vincent has collaborated with several professionals in his field, including Shelly Krebs and Gina Donofrio. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Vincent Dussupt's innovative work in developing antibodies for the Zika virus showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against viral infections, and his patent reflects the potential for significant advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…